Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
AGK2
i
Other names:
AGK2
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Chongqing Medical University, Harvard Medical School, Shanghai Jiao Tong University
Drug class:
SIRT2 inhibitor
‹
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
KRAS mutation
Colorectal Cancer
KRAS mutation
Colorectal Cancer
AGK2
Sensitive: D – Preclinical
AGK2
Sensitive
:
D
AGK2
Sensitive: D – Preclinical
AGK2
Sensitive
:
D
TP53 mutation
Colorectal Cancer
TP53 mutation
Colorectal Cancer
AGK2
Sensitive: D – Preclinical
AGK2
Sensitive
:
D
AGK2
Sensitive: D – Preclinical
AGK2
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.